Kolon TissueGene Amends Lawsuit Disclosure with Partial Withdrawal of Plaintiffs and Reduced Claim
Kolon TissueGene has amended its disclosure regarding a damages lawsuit filed in 2019, with three additional plaintiffs withdrawing, reducing the total number of plaintiffs to 965 and the claim amount to approximately 29,903,796,052 KRW.
The claim amount represents 13.47% of equity of 221,976,975,980 KRW, still a material risk factor for the company.
The company will continue to defend through legal counsel, and this amendment is a routine disclosure unrelated to capital changes or fundraising.
[AI Summary]The amendment shows a slight reduction in the lawsuit claim due to partial plaintiff withdrawals, but the claim remains significant at 13.47% of equity, indicating ongoing litigation risk. No capital or strategic changes suggest limited stock price impact, but investors should monitor legal developments.
KOSDAQ Filing Information
[Correction of Description] Filing of Lawsuits, etc. and Application (Claims of Specified Amount or More)